Arranon Injection
Product Images NDC 0078-0683

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Arranon (NDC 0078-0683). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Structural Formula For Nelarabine Is 2-amino-9-b-d-arabinofuranosyl-6-methoxy-9h-purine. It Has The Molecular Formula C11h15n5o5 And A Molecular Weight Of 297.27. (Arranon 01)

Chemical structure diagram of nelarabine, the active ingredient in Arranon injection. The structure shows a purine nucleoside analog with methoxy, amino, and hydroxyl functional groups arranged around a ribose sugar moiety.*

FDA Label Image

Principal Display Panel Ndc 0078-0683-06 (Arranon 02)

The packaging label for Arranon (nelarabine) Injection, an intravenous injection with a strength of 5 mg/mL (250 mg/50 mL). The label indicates it contains six 50-mL vials. The labeler is Novartis Pharmaceuticals Corporation, and it notes manufacturing by Glaxo Operations UK Limited in England. The label includes NDC 0078-0683-06 and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.